Can a drug developed for sickle cell anemia mitigate lung damage in patients with COVID-19?
Scientists around the globe are working to identify approved and investigational drugs that can be repurposed to treat COVID-19.
May 13, 2020
0
3
Scientists around the globe are working to identify approved and investigational drugs that can be repurposed to treat COVID-19.
May 13, 2020
0
3
In severe cases of COVID-19, a massive release of the endogenous protein HMGB1 in the lungs may contribute to pulmonary inflammation and tissue damage, according to a review article published today in the scientific journal ...
May 8, 2020
0
11
Exposure to bisphenol A (BPA), an industrial chemical used to make certain plastics and resins, inner coatings for food cans and bottle tops, thermal paper used in store receipts, dental sealants and other products is a concern ...
May 7, 2020
0
52
Researchers from the Faculty of Medicine of the University of Barcelona and the CELLEX Biomedical Research Centre from IDIBAPS, in collaboration with scientists from the University of Sydney, University of London and the ...
May 6, 2020
0
32
Senescence is a response to cell damage and stress characterized by the arrest of the cell cycle. When aging, cells permanently stop dividing, thus preventing the propagation of damaged and dysfunctional cells. However, eventually, ...
May 5, 2020
0
14
A new test can detect glaucoma progression 18 months earlier than the current gold standard method, according to results from a UCL-sponsored clinical trial.
May 3, 2020
0
55
Multiple sclerosis (MS) is known as "the disease with a thousand faces" because symptoms and progression can vary dramatically from patient to patient. But every MS patient has one thing in common: Cells of their body's own ...
Apr 20, 2020
0
354
A new study by researchers in the Quadram Institute has provided insights into how interactions between gut microbes and cells of the immune system contribute to cholestatic liver disease.
Apr 20, 2020
0
19
Many cancers can be successfully treated, but treatment itself often comes with risks as well. Cancer therapy that uses anthracyclines—a class of commonly used chemotherapy drugs—has been associated with heart damage ...
Apr 9, 2020
0
7
A drug used for cancer therapy has shown promise in reversing kidney damage caused by systemic lupus erythematosus (SLE, or lupus), according to a Yale-led study published April 8 in the journal Science Translational Medicine.
Apr 8, 2020
0
506